solid tumors

Janux Rides Its TRACTr to Validation in Prostate Cancer and More Solid Tumors

A Janux Therapeutics T cell engager has early clinical data showing improvement in cases of advanced prostate cancer, validating the technology platform that produced the therapy. Janux is now leveraging its soaring stock price to raise $175 million in a stock offering.

By Frank Vinluan

BioPharma, Pharma

Roche licenses glycoproteomics-based antibody technology from GO Therapeutics

The company sees its platform as potentially overcoming off-target toxicities in existing antibody-drug conjugates, bispecific antibodies and solid tumor CAR-Ts.

By Alaric DeArment

The Top Appointment Scheduling Software for Wellness Clinics

Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.

By PatientNow

Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies

Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.

By Lone Star IV Medics

These Are the Top-Rated Autism Therapy Centers in Texas

There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.

By Behavioral Innovations